[ad_1] CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding weight loss drug market. Analysts say upcoming data on Pfizer’s…
Tag: Novo Nordisk A/S
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
[ad_1] Wegovy, an injectable prescription weight loss medicine that has helped people with obesity. Michael Siluk | UCG | Getty Images Novo Nordisk on Thursday said 80% of U.S. patients…
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March…
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
[ad_1] Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that…
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
[ad_1] CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected adjusted loss for the third quarter as the drugmaker recorded charges largely related to…
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
[ad_1] Weight loss has always been big business, but it’s exploded of late due to surging demand for Ozempic, Wegovy and other new diabetes and obesity drugs. In the first…
CNBC Daily Open: Oil deals and awaiting tech earnings
[ad_1] Traders work on the floor of the New York Stock Exchange on April 26, 2023 in New York City. Michael M. Santiago | Getty Images This report is from…
Sanofi to offer insulin product for $35 to all Americans through GoodRx
[ad_1] Sanofi Lantus brand insulin pens are arranged for a photograph in Brooklyn, New York, on April 5, 2019. Alex Flynn | Bloomberg | Getty Images Americans, regardless of their…